Zephyrus Innovations appoints David Whitaker as Chief Technology Officer
Vancouver, Canada – 30 May 2023: Zephyrus Innovations (Zephyrus), a privately-owned medical device company designing and manufacturing safety syringes and Closed System Transfer Devices (CSTDs), today announces the appointment of David Whitaker as Chief Technology Officer.
David brings with him more than 20 years’ experience in the development and manufacture of medical devices. Until recently, he was Operations Director at Atlas Genetics / Binx Health Ltd. where he took the Company’s first product, a point of care PCR system for the detection of infectious diseases, from prototype through to commercial supply.
